Shaikh O - Search Results

1

Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.

Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J. Malik SM, et al. Among authors: shaikh o. Liver Transpl. 2009 Dec;15(12):1843-51. doi: 10.1002/lt.21943. Liver Transpl. 2009. PMID: 19938117 Free article.

2

Caroli's disease and liver transplantation.

Habib S, Shaikh OS. Habib S, et al. Liver Transpl. 2008 Jan;14(1):2-3. doi: 10.1002/lt.21379. Liver Transpl. 2008. PMID: 18161795 Free article. No abstract available.

3

Outcome after liver transplantation for NASH cirrhosis.

Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Malik SM, et al. Among authors: shaikh o. Am J Transplant. 2009 Apr;9(4):782-93. doi: 10.1111/j.1600-6143.2009.02590.x. Am J Transplant. 2009. PMID: 19344467 Free article.

4

Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation.

El Hajj II, Malik SM, Alwakeel HR, Shaikh OS, Sasatomi E, Kandil HM. El Hajj II, et al. World J Gastroenterol. 2009 Aug 21;15(31):3937-9. doi: 10.3748/wjg.15.3937. World J Gastroenterol. 2009. PMID: 19701976 Free PMC article.

5

Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.

Tao R, Ruppert K, Cruz RJ Jr, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes PA, de Vera ME. Tao R, et al. Among authors: shaikh o. Liver Transpl. 2010 Nov;16(11):1288-95. doi: 10.1002/lt.22168. Liver Transpl. 2010. PMID: 21031544 Free article.

6

Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.

Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P; HIVTR Investigators. Terrault N, et al. Among authors: shaikh o. Am J Transplant. 2014 May;14(5):1129-35. doi: 10.1111/ajt.12668. Epub 2014 Mar 17. Am J Transplant. 2014. PMID: 24636466 Free article.

7

Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES.

Butt AA, Yan P, Shaikh OS, Chung RT, Sherman KE; ERCHIVES study. Butt AA, et al. Liver Int. 2016 May;36(5):651-8. doi: 10.1111/liv.13036. Epub 2015 Dec 25. Liver Int. 2016. PMID: 26616353

8

Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES.

Butt AA, Yan P, Shaikh OS, Chung RT, Sherman KE; ERCHIVES study. Butt AA, et al. Liver Int. 2016 Sep;36(9):1275-83. doi: 10.1111/liv.13103. Epub 2016 Mar 24. Liver Int. 2016. PMID: 26928927

9

Association between opioid use and readmission following liver transplantation.

Rogal S, Mankaney G, Udawatta V, Good CB, Chinman M, Zickmund S, Bielefeldt K, Jonassaint N, Jazwinski A, Shaikh O, Hughes C, Humar A, DiMartini A, Fine MJ. Rogal S, et al. Among authors: shaikh o. Clin Transplant. 2016 Oct;30(10):1222-1229. doi: 10.1111/ctr.12806. Epub 2016 Aug 24. Clin Transplant. 2016. PMID: 27409580

10

Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral Therapy.

Habib S, Malik S, Fu B, Chang J, Nalesnik M, Humar A, Shaikh OS. Habib S, et al. Gastroenterology Res. 2015 Dec;8(6):281-290. doi: 10.14740/gr694w. Epub 2015 Dec 31. Gastroenterology Res. 2015. PMID: 27785310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page